Cargando…

Cancer predisposing BARD1 mutations in breast-ovarian cancer families

Detalles Bibliográficos
Autores principales:	Ratajska, Magdalena, Matusiak, Magdalena, Brożek, Izabela, Stukan, Maciej, Śniadecki, Marcin, Dębniak, Jarosław, Wydra, Dariusz, Limon, Janusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518228/ http://dx.doi.org/10.1186/1897-4287-10-S4-A10

Ejemplares similares

Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example
por: Klonowska, Katarzyna, et al.
Publicado: (2015)

Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients
por: Koczkowska, Magdalena, et al.
Publicado: (2018)

Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing
por: Ratajska, Magdalena, et al.
Publicado: (2014)

HER2 Amplification Has no Prognostic Value in Sporadic and Hereditary Ovarian Tumours
por: Brożek, Izabela, et al.
Publicado: (2006)

BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer
por: Pilyugin, Maxim, et al.
Publicado: (2021)

BARD1 and Breast Cancer: The Possibility of Creating Screening Tests and New Preventive and Therapeutic Pathways for Predisposed Women
por: Śniadecki, Marcin, et al.
Publicado: (2020)

Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer
por: Ratajska, Magdalena, et al.
Publicado: (2017)

Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability
por: Pilyugin, Maxim, et al.
Publicado: (2016)

Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects
por: Wiczling, Paweł, et al.
Publicado: (2019)

Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases
por: Brozek, Izabela, et al.
Publicado: (2012)

Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers
por: Alenezi, Wejdan M., et al.
Publicado: (2020)

Differential Expression of BARD1 Isoforms in Melanoma
por: McDougall, Lorissa I., et al.
Publicado: (2021)

Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours
por: Swierzko, Anna St., et al.
Publicado: (2014)

Detection of somatic BRCA1/2 mutations in ovarian cancer – next‐generation sequencing analysis of 100 cases
por: Koczkowska, Magdalena, et al.
Publicado: (2016)

BARD1 is a Low/Moderate Breast Cancer Risk Gene: Evidence Based on an Association Study of the Central European p.Q564X Recurrent Mutation
por: Suszynska, Malwina, et al.
Publicado: (2019)

Biophysical evaluation to categorize pathogenicity of cancer-predisposing mutations identified in the BARD1 BRCT domain
por: Choudhary, Rajan Kumar, et al.
Publicado: (2018)

Mutations spectrum in hereditary disorders predisposing to occurrence of intestine polyposis in Poland
por: Plawski, Andrzej, et al.
Publicado: (2012)

Germline mutations of BRCA1-associated RING domain (BARD1) gene in breast and/or ovarian families negative for BRCA1 and 2 alterations
por: Ghimenti, C, et al.
Publicado: (2000)

Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours
por: Szala, Agnieszka, et al.
Publicado: (2013)

Ultrasound Measurement of Tumor-Free Distance from the Serosal Surface as the Alternative to Measuring the Depth of Myometrial Invasion in Predicting Lymph Node Metastases in Endometrial Cancer
por: Liro, Marcin, et al.
Publicado: (2021)

Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?
por: Stempa, Klaudia, et al.
Publicado: (2021)

Incorporation of Tumor-Free Distance and Other Alternative Ultrasound Biomarkers into a Myometrial Invasion-Based Model Better Predicts Lymph Node Metastasis in Endometrial Cancer: Evidence and Future Prospects
por: Liro, Marcin, et al.
Publicado: (2022)

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Lung and Intercostal Upper Abdomen Ultrasonography for Staging Patients with Ovarian Cancer: A Method Description and Feasibility Study
por: Stukan, Maciej, et al.
Publicado: (2020)

Dualistic Role of BARD1 in Cancer
por: Cimmino, Flora, et al.
Publicado: (2017)

Ultrasound and Clinical Preoperative Characteristics for Discrimination Between Ovarian Metastatic Colorectal Cancer and Primary Ovarian Cancer: A Case-Control Study
por: Stukan, Maciej, et al.
Publicado: (2019)

Microelements as risk factors for cancer of the lung and larynx
por: Jaworska-Bieniek, Katrzyna, et al.
Publicado: (2012)

Thousands of Women’s Lives Depend on the Improvement of Poland’s Cervical Cancer Screening and Prevention Education as Well as Better Networking Strategies Amongst Cervical Cancer Facilities
por: Śniadecki, Marcin, et al.
Publicado: (2022)

Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer
por: Weber-Lassalle, Nana, et al.
Publicado: (2019)

Spectrum of NIPBL gene mutations in Polish patients with Cornelia de Lange syndrome
por: Kuzniacka, Alina, et al.
Publicado: (2012)

Erratum to: Spectrum of NIPBL gene mutations in Polish patients with Cornelia de Lange syndrome
por: Kuzniacka, Alina, et al.
Publicado: (2013)

Selenium and the risk of cancer of the lung and larynx. A case-control study from a region with low selenium
por: Jaworska, Katrzyna, et al.
Publicado: (2012)

Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations
por: Suszynska, Malwina, et al.
Publicado: (2020)

Copper as diagnostic marker of cancers
por: Muszyńska, Magdalena, et al.
Publicado: (2015)

Iron and breast cancer risk
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Magnesium as a diagnostic marker of cancer
por: Marciniak, Wojciech, et al.
Publicado: (2015)

BARDES coming of age?
Publicado: (2022)

Selenium as diagnostic marker of cancers
por: Jaworska-Bieniek, Katarzyna, et al.
Publicado: (2015)

Zinc as diagnostic marker of cancers
por: Kaczmarek, Katarzyna, et al.
Publicado: (2015)

Iron as diagnostic marker of cancer
por: Sukiennicki, Grzegorz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_06mps1euthr8v214f4jr46ktdr